Navegação por título
Itens para a visualização no momento 2500-2519 of 2964
-
Safe delivery for pregnancies affected by COVID‐19
(2020)Since December 2019, a new coronavirus infection (COVID‐19) has rapidly become prevalent in central China. On the basis of knowledge obtained from a previous coronavirus outbreak, pregnant women are believed to be susceptible ... -
Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review
(2020-05-14)Introduction: Proper strategies to minimise the risk of infection in individuals handling the bodies of deceased persons infected with 2019 novel coronavirus (2019-nCoV) are urgently needed. The objective of this study was ... -
Safe Ramadan practices in the context of the COVID-19. Interim guidance, 15 April 2020
(2020-04-15)Background: The holy month of Ramadan is marked by social and religious gatherings where Muslim families and friends unite to break their fast together, after sunset during iftar or before dawn during suhour. Many Muslims ... -
Safety and effectiveness of dose-sparing strategies for seasonal influenza vaccine
(2020-08-04)The current evidence for the administration of intramuscular influenza vaccines suggests there is no significant difference in safety and clinical effectiveness with the use of low-dose compared to full-dose vaccines, which ... -
Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
(2020-08)Background: During the initial phases of the coronavirus disease 2019 (COVID-19) epidemic, there was an unfounded fervor surrounding the use of hydroxychloroquine (HCQ); however, recently, the Centers for Disease Control ... -
Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
(2016-07)The Zika virus is passed to humans by infected mosquitos. It usually causes fever, rash, joint pain, and red eyes. Recently, some cases of microcephaly (abnormally small head) were reported in babies born to mothers infected ... -
Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe
(2020-05)The novel coronavirus, SARS-CoV-2, was first detected as a respiratory illness in December 2019 in Wuhan City, China. Since then, coronavirus disease 2019 (COVID-19) has impacted every aspect of our lives worldwide. In a ... -
Safety Protocols for COVID-19
(2020-03-16)ST. JOHN’S Antigua, March 16th 2020 - The Antigua Public Utilities Authority (APUA) recognizes it’s social and corporate responsibility in ensuring a steady and reliable supply of the essential services that we offer are ... -
Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
(2017)The clinical study will assess the safety, tolerability, and immunogenicity of mRNA-1325 in healthy adult subjects. Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: Parallel ... -
Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis
(2020-08-04)Background: COVID-19 is a serious and potentially deadly disease. Early diagnosis of infected individuals will play an important role in stopping its further escalation. The present gold standard for sampling is the ... -
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
(2020-04-22)Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal ... -
Salud mental en situaciones de epidemias
(2020)Este documento tiene como objetivo general dotar de las directrices prácticas de apoyo psicosocial en situación de emergencia y desastre, a los equipos de respuesta, para atención a las personas y comunidades afectadas de ... -
Sarilumab use in severe SARS-CoV-2 pneumonia
(2020-05-18)Interleukin-6 signal blockade has shown preliminary beneficial effects in treating aberrant host inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Objective: to describe the effect of off-label ... -
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts
(2020-06-04)The ongoing outbreak of Coronavirus Disease 2019 (COVID-19) has become a global public health emergency. SARS-coronavirus-2 (SARS-CoV-2), the causative pathogen of COVID-19, is a positive-sense single-stranded RNA virus ... -
SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis
(2020-05-05)The effect of the rapid accumulation of nonsynonymous mutations on the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not yet known. The 3a protein is unique to SARS-CoV and is essential ... -
SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria
(2020-04-09)[Abstract]. Purpose: Community transmission of SARS-CoV-2 was detected in Spain in February 2020, with 216% intensive care unit (ICU) capacity expanded in Vitoria by March 18th, 2020. Methods: We identified patients from ... -
SARS-CoV-2 outbreak on the Caribbean islands of the Dutch Kingdom: a unique challenge
(2020-08-05)[ABSTRACT]. As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic progresses, countries are depending on one another to acquire knowledge regarding effective measures to contain the virus. Public ... -
SARS-CoV-2 pandemic in Italy: ethical and organizational considerations
(2020-05-25)The current SARS-CoV-2 pandemic is still raging in Italy. The country is currently plagued by a huge burden of virus relatedcases and deaths. So far, the disease has highlighted a number of problems, some in common with ...